Perspective Therapeutics announced FDA Fast Track Designation for PSV359 to treat advanced FAP-positive solitary fibrous ...

Options trading asks far more of a platform than a standard trading account can deliver. What you need is software built ...

***Money is not a client of any investment adviser featured on this page. The information provided on this page is for ...

Find the best free trading journal in 2026. We compare 6 free platforms for day trading, forex, options, and beginners to ...

RBC Capital downgrades to ‘Sector Perform’ from ‘Outperform’ and cuts price target to $1 from $10. ・Caribou will also reduce its workforce. ・The company had $113.8 million in cash, cash equivalents ...

Space Exploration Technologies Corp. stocks have been trading up by 3.64 percent after securing a landmark ...

Crescent Biopharma's CR-002 clinical trial for advanced solid tumors set to begin Q4 2026, with initial data due mid-2027.

Richardson Electronics gets a Hold rating, awaiting consistent profitability and free cash flow before considering a more bullish stance. Read more on RELL.

FINRA-Stanford study of 2,861 investors: 54 percent with basic literacy would take a 'guaranteed' 25% return, vs 35 percent ...

You may find your first trading app perfect until the day you need something it does not offer. A clean interface may be enough when you are buying a few stocks, but things can change quickly when you ...

CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today that they have entered into a definitive agreement, under which ...